Sign In
Buy TGTX
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
TG Therapeutics (TGTX) Upgraded to Buy: Here's Why
05:00pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does TG Therapeutics (TGTX) Have the Potential to Rally 151% as Wall Street Analysts Expect?
02:55pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 151.2% in TG Therapeutics (TGTX). While the effectiveness of this highly sought-after metric is questionable, t
TG Therapeutics (TGTX) Upgraded to Buy: Here's Why
01:33pm, Wednesday, 16'th Nov 2022
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TG Therapeutics (TGTX) Q3 2022 Earnings Call Transcript
01:14pm, Saturday, 12'th Nov 2022
TG Therapeutics (NASDAQ:TGTX ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Jenna Bosco - Investor Relations Michael Weiss - Chairman and Chief Executive Officer
Why Shares of TG Therapeutics Climbed 59.9% This Week
12:48am, Saturday, 12'th Nov 2022 The Motley Fool
The company got a big bump from the FDA.
Why Shares of TG Therapeutics Climbed 59.9% This Week
07:48pm, Friday, 11'th Nov 2022
The company got a big bump from the FDA.
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
10:10am, Friday, 11'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions relat
Why TG Therapeutics' Shares Rose 63.37% on Thursday
10:04pm, Thursday, 10'th Nov 2022 The Motley Fool
The company had a nugget of good news in its third-quarter report.
Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher
07:43pm, Thursday, 10'th Nov 2022 Benzinga
U.S. stocks traded sharply higher toward the end of trading, with the NASDAQ Composite jumping over 6% on Thursday.
The Dow traded up 3.15% to 33,536.81 while the NASDAQ climbed 6.24% to 10,999.19. T
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
06:05pm, Thursday, 10'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's vo
Why TG Therapeutics' Shares Rose 63.37% on Thursday
05:04pm, Thursday, 10'th Nov 2022
The company had a nugget of good news in its third-quarter report.
TG Therapeutics (TGTX) Reports Q3 Loss, Lags Revenue Estimates
01:45pm, Thursday, 10'th Nov 2022 Zacks Investment Research
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 21.21% and 97.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business Update
07:30am, Tuesday, 08'th Nov 2022
Conference call to be held Thursday, November 10, 2022 at 8:30 AM ET Conference call to be held Thursday, November 10, 2022 at 8:30 AM ET
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting exploratory analyses from the ULTIMATE I & II Phase 3 trials evaluating u
NEW YORK, Oct. 13, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations, highlighting data from the ULTIMATE I & II Phase 3 trials evalua
